Suppr超能文献

围手术期使用度洛西汀和依托考昔改善腰椎椎板切除术后疼痛:一项随机、双盲、对照研究。

Perioperative Duloxetine and Etoricoxibto improve postoperative pain after lumbar Laminectomy: a randomized, double-blind, controlled study.

作者信息

Attia Josef Zekry, Mansour Haidy Salah

机构信息

Departments of Anesthesiology and I.C.U Al-Minia University, Faculty of Medicine, Minia University, Minia, 61111, Egypt.

出版信息

BMC Anesthesiol. 2017 Dec 2;17(1):162. doi: 10.1186/s12871-017-0450-z.

Abstract

BACKGROUND

Duloxetine, Etoricoxib and opioid are of the commonly administered drugs in Lumbar laminectomy. The aim of this study is to assess the effect of perioperative use of Duloxetine in combination with Etoricoxib on postoperative pain and opioid requirements.

METHODS

One hundred twenty patients with ASA physical status were enrolled with age between 18 and 70 years. Patients were divided randomly into four groups of 30 patients: group P received placebo, group E received etoricoxib 120 mg, group D received duloxetine 60 mg and group D/E received duloxetine 60 mg capsules and etoricoxib 120 mg; 1 h before surgery and 24 h after.

RESULTS

Neither Duloxetine nor etoricoxib individually had effect on pain with movement, while their combination revealed a significant reduction in pain scores over the entire postoperative period at rest and on movement. Etoricoxib showed a significant decrease in pain at all times at rest when compared with group P, while it showed significant pain decrease only at 0, 2 and 4 h when compared with group D. On the other hand duloxetine alone showed significant decrease in pain at rest at 24 h and 48 h when compared with group P. ConcerningMorphine requirement after 24 h.; it wassignificantly lower in the D/E group in comparison with groups P, E and D. It should be noted also that there was a significant decrease morphine requirement in both groups E and D.

CONCLUSION

The perioperative administration of the combination of etoricoxib and duloxetine improved analgesia and reduced opioid consumption without significant side effects.

TRIAL REGISTRATION

ISRCTN48329522 . 17 June 2017.

摘要

背景

度洛西汀、依托考昔和阿片类药物是腰椎椎板切除术中常用的药物。本研究的目的是评估围手术期使用度洛西汀联合依托考昔对术后疼痛和阿片类药物需求的影响。

方法

纳入120例年龄在18至70岁之间、美国麻醉医师协会(ASA)身体状况分级的患者。患者被随机分为四组,每组30例:P组接受安慰剂,E组接受120 mg依托考昔,D组接受60 mg度洛西汀,D/E组接受60 mg度洛西汀胶囊和120 mg依托考昔;于手术前1小时和术后24小时给药。

结果

度洛西汀和依托考昔单独使用时对活动时疼痛均无影响,而二者联合使用在术后整个静息期和活动期的疼痛评分均显著降低。与P组相比,依托考昔在所有静息时间点的疼痛均显著降低,而与D组相比,仅在0、2和4小时疼痛显著降低。另一方面,与P组相比,单独使用度洛西汀在24小时和48小时静息时疼痛显著降低。关于术后24小时的吗啡需求量;D/E组与P组、E组和D组相比显著更低。还应注意的是,E组和D组的吗啡需求量均显著降低。

结论

围手术期给予依托考昔和度洛西汀联合用药可改善镇痛效果并减少阿片类药物用量,且无明显副作用。

试验注册号

ISRCTN48329522。2017年6月17日。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/258f/5712123/130073aa061b/12871_2017_450_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验